FIRST-IN-HUMAN STUDY DEMONSTRATES Qi601 CAN PHYSICALLY CAPTURE MICROPLASTICS

Phase 1positiveQi601Positive

AI Analysis

Summary

Peer-reviewed research demonstrates Qi601 as the first technology to provide human proof-of-concept evidence of microplastics capture. The first-in-human study shows positive results for this intentionally designed microplastics capture technology.

Clinical Trial Data

Phase

first-in-human

Primary Endpoint

Met

Outcome Details

first human proof-of-concept evidence demonstrating Qi601 can physically capture microplastics

Importance:6/10

Sentiment:

0.70

microplasticsfirst-in-humanproof-of-conceptpeer-reviewed

Related Companies

$TRAX

Read the original article

Published by PR Newswire Clinical Trials on September 30, 2026 11:32 PM

Read Original